IRHYTHM TECHNOLOGIES, INC. Financials iRhythm Technologies, Inc.
Equities
IRTC
US4500561067
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 111.9 USD | +0.58% |
|
-0.16% | +4.55% |
| Mar. 08 | IRhythm Technologies Closes $661 Million Notes Offering | MT |
| Mar. 05 | Irhythm Technologies Insider Sold Shares Worth $360,983, According to a Recent SEC Filing | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,813 | 6,849 | 3,463 | 2,820 | 3,281 | 3,483 | - | - |
| Enterprise Value (EV) 1 | 1,827 | 6,793 | 3,357 | 2,642 | 3,280 | 3,437 | 3,408 | 3,342 |
| P/E ratio | -31.5 x | -150 x | -34 x | -24.1 x | -26.5 x | -38.4 x | -68.5 x | -689 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 8.45 x | 25.8 x | 10.7 x | 6.86 x | 6.66 x | 6 x | 5.06 x | 4.31 x |
| EV / Revenue | 8.52 x | 25.6 x | 10.4 x | 6.43 x | 6.66 x | 5.92 x | 4.95 x | 4.13 x |
| EV / EBITDA | -35.6 x | -187 x | -37.2 x | -235 x | -674 x | 166 x | 51.3 x | 28.5 x |
| EV / FCF | -43.2 x | -249 x | -51 x | -50 x | -36.2 x | -186 x | 216 x | - |
| FCF Yield | -2.32% | -0.4% | -1.96% | -2% | -2.76% | -0.54% | 0.46% | - |
| Price to Book | 13.4 x | 20.2 x | 12.4 x | 11.8 x | 15.8 x | 13 x | 11.1 x | 8.67 x |
| Nbr of stocks (in thousands) | 26,624 | 28,871 | 29,426 | 30,111 | 30,651 | 31,121 | - | - |
| Reference price 2 | 68.09 | 237.2 | 117.7 | 93.67 | 107.0 | 111.9 | 111.9 | 111.9 |
| Announcement Date | 2/27/20 | 2/25/21 | 2/23/22 | 2/23/23 | 2/22/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 214.6 | 265.2 | 322.8 | 410.9 | 492.7 | 580.8 | 688.1 | 808.2 |
| EBITDA 1 | -51.31 | -36.37 | -90.28 | -11.26 | -4.863 | 20.74 | 66.47 | 117.1 |
| EBIT 1 | -54.76 | -43.67 | -99.94 | -87.18 | -125.2 | -88.37 | -54.6 | -15.41 |
| Operating Margin | -25.52% | -16.47% | -30.96% | -21.21% | -25.4% | -15.21% | -7.93% | -1.91% |
| Earnings before Tax (EBT) 1 | -54.5 | -43.6 | -101 | -115.9 | -122.7 | -89.83 | -51.56 | -14.73 |
| Net income 1 | -54.57 | -43.83 | -101.4 | -116.2 | -123.4 | -90.08 | -51.81 | -5.255 |
| Net margin | -25.43% | -16.53% | -31.4% | -28.27% | -25.05% | -15.51% | -7.53% | -0.65% |
| EPS 2 | -2.160 | -1.580 | -3.460 | -3.880 | -4.040 | -2.916 | -1.634 | -0.1625 |
| Free Cash Flow 1 | -42.32 | -27.31 | -65.82 | -52.84 | -90.52 | -18.5 | 15.8 | - |
| FCF margin | -19.72% | -10.3% | -20.39% | -12.86% | -18.37% | -3.19% | 2.3% | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | 23.77% | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 2/27/20 | 2/25/21 | 2/23/22 | 2/23/23 | 2/22/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 85.43 | 81.8 | 92.38 | 102.1 | 103.9 | 112.6 | 111.4 | 124.1 | 124.6 | 132.5 | 128.4 | 146.5 | 147.8 | 157.8 | 154.8 |
| EBITDA 1 | -20.86 | -29.17 | -4.753 | -4.954 | -2.624 | 1.069 | -11.99 | 4.394 | 0.363 | 2.373 | -4.022 | 2.014 | 8.997 | 13.28 | - |
| EBIT 1 | -23.28 | -32.2 | -21.8 | -23.45 | -21.09 | -20.7 | -39.5 | -18.87 | -27.6 | -39.18 | -31.16 | -22.87 | -18.49 | -15.39 | -27.5 |
| Operating Margin | -27.25% | -39.36% | -23.6% | -22.98% | -20.3% | -18.38% | -35.45% | -15.2% | -22.15% | -29.57% | -24.26% | -15.61% | -12.51% | -9.75% | -17.77% |
| Earnings before Tax (EBT) 1 | -23.64 | -32.43 | -50.56 | -23.86 | -21.34 | -20.12 | -39.02 | -18.27 | -26.92 | -38.44 | -31.43 | -23.77 | -20.1 | -16.02 | -26.61 |
| Net income 1 | -23.73 | -32.49 | -50.61 | -23.9 | -21.45 | -20.2 | -39.11 | -18.48 | -27.12 | -38.7 | -31.48 | -23.85 | -20.17 | -16.11 | -26.66 |
| Net margin | -27.78% | -39.72% | -54.78% | -23.42% | -20.65% | -17.94% | -35.1% | -14.89% | -21.76% | -29.2% | -24.52% | -16.28% | -13.65% | -10.21% | -17.23% |
| EPS 2 | -0.8100 | -1.100 | -1.710 | -0.8000 | -0.7100 | -0.6700 | -1.290 | -0.6100 | -0.8900 | -1.260 | -0.9729 | -0.7643 | -0.6514 | -0.5271 | -0.6380 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/4/21 | 2/23/22 | 5/5/22 | 8/4/22 | 11/1/22 | 2/23/23 | 5/4/23 | 8/3/23 | 11/2/23 | 2/22/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 14.5 | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 55.6 | 106 | 178 | 1.22 | 45.4 | 75.1 | 141 |
| Leverage (Debt/EBITDA) | -0.282 x | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -42.3 | -27.3 | -65.8 | -52.8 | -90.5 | -18.5 | 15.8 | - |
| ROE (net income / shareholders' equity) | -58.2% | -18.4% | -32.6% | -44.7% | -54.9% | -35.4% | -19.7% | -5.54% |
| ROA (Net income/ Total Assets) | -25.8% | -10.7% | -20.8% | -25.5% | -28% | -20.3% | -15.2% | -7.85% |
| Assets 1 | 211.9 | 408.9 | 487.4 | 455.6 | 440.7 | 444.5 | 340.3 | 66.98 |
| Book Value Per Share 2 | 5.070 | 11.80 | 9.480 | 7.940 | 6.790 | 8.580 | 10.10 | 12.90 |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | 20.5 | 13.6 | 28.1 | 29.8 | 40.4 | 45 | 53 | 61 |
| Capex / Sales | 9.53% | 5.11% | 8.69% | 7.26% | 8.2% | 7.75% | 7.7% | 7.55% |
| Announcement Date | 2/27/20 | 2/25/21 | 2/23/22 | 2/23/23 | 2/22/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
111.9
USD
Average target price
138.5
USD
Spread / Average Target
+23.76%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.55% | 3.48B | |
| -12.80% | 156M | |
| -15.69% | 81.85M | |
| +30.43% | 59.71M |
- Stock Market
- Equities
- IRTC Stock
- Financials iRhythm Technologies, Inc.
